Bayer is launching major recall campaigns for aspirin pills

Leaky packaging: Bayer recalls aspirin
The pharmaceutical company Bayer AG has announced a recall for certain drug batches. Affected are aspirin tablets, which could discolor due to leaking packaging. A security risk does not exist according to the manufacturer.

Leaky packaging detected
Aspirin is probably one of the best known drugs worldwide. It is used among other things for headache, fever or toothache. The manufacturer of the tablets, Bayer AG, has now started a recall for certain batches of the drug. According to the pharmaceutical company, leaking packaging was detected in the affected products.

The pharmaceutical manufacturer Bayer recalls certain batches of its aspirin medicines. The affected tablets may discolor due to leaking packaging. (Image: Africa Studio / fotolia.com)

Tablets may discolour
"In the course of follow-up examinations, leaks in the primary packaging were occasionally detected with the medicines Aspirin Plus C and Aspirin Effect," Bayer reports in a press release.

"Aspirin Plus C effervescent tablets and Aspirin Effect granules are sensitive to moisture and are packaged in aluminum sachets. A leak can lead to a discoloration of the Aspirin Plus C tablet and, in addition to aspirin effect, to a clumping of the granules, "it continues.

No health hazard
Affected by the recall are:
"Aspirin Plus C", 10 pieces, effervescent tablets (PZN 01406632) Ch.-B .: BTAGU51, BTAH400, BTAH8G0
"Aspirin Plus C", 20 pieces, effervescent tablets (PZN 01894063) Ch.-B .: BTAH8U0, BTAHJL2
"Aspirin Plus C", 40 pieces, effervescent tablets (PZN 03464237) Ch.-B .: BTAHJT2, BTAHJT3, BTAHJT4
"Aspirin Effect", 10 pieces, granules (PZN 01405147) Ch.-B .: BTT1DWK

According to the company, there is no effect on the compatibility or effectiveness of the affected products: "There is no health risk for the consumer. If the consumer finds a clumping or discoloration in one of the recalled batches, he can complain about his pharmacy. "

It is said that most of the affected batches are still in wholesaling or pharmacies. Only a few of these medicines can have reached end customers. (Ad)